comparemela.com
Home
Live Updates
How Dr Lal Pathlabs - Breaking News
Pages:
Latest Breaking News On - How dr lal pathlabs - Page 1 : comparemela.com
Healthcare-focused growth fund Jashvik Capital completes first close of maiden fund
The SEBI (Securities and Exchange Board of India) registered, Category II Alternative Investment Fund (AIF), announced in July this year, expects to make its final close within a year. It will invest with a ticket size ranging from $10-50 million.
Naresh patwari
Lal pathlabs
Vijender singh
Mckinsey company
Exchange board of india
Category ii alternative investment fund
Ta associates
Jashvik capital
Exchange board
Investment fund
Anil matai
Managing director
Zydus healthcare
Chief executive officer
Metropolis healthcare
How dr lal pathlabs
vimarsana © 2020. All Rights Reserved.